The CDC and other health agencies recommend adults aim for at least 150 minutes of moderate aerobic activity, along with two muscle-strengthening sessions a week. However, research suggests you may ...

The Trump administration this week announced it will end a Biden-era subsidy that was aimed at reducing premiums for drug coverage for people on Medicare. “The Biden admin gave BILLIONS of taxpayer ...

The two Chrome updates in June patched more bugs than the 23 updates before them. Now, Google is ramping up its patching schedule thanks to AI-assisted vulnerability discovery. In a report published ...

Millions of older adults on Medicare prescription drug coverage could face steeper monthly costs in 2027, after the Trump administration concludes a temporary subsidy program that has helped offset ...

Detailed phase 3 results suggest the two-drug combination of Gilead Sciences’ lenacapavir and Merck & Co.’s islatravir has what it takes to become the first complete weekly pill for the treatment of ...

QDTE's daily 0DTE Nasdaq-100 strategy pays weekly at a 45% yield, generating over $17,000 more annually than JEPQ on a $50,000 position. QDTE's 0.97% expense ratio and return-of-capital distributions ...

Nearly one million student-loan borrowers have moved out of a generous repayment plan that the Trump administration is winding down. Some of the more than 7 million borrowers who were in the Saving on ...

Netflix has a problem: No one is watching the second seasons of its biggest hits. This isn’t a new trend, but it is now becoming a dire one, with executives at the company scrambling around asking ...

The Walt Disney Company on Monday wrote in a regulatory filing with the Federal Communications Commission that its long-running ABC daytime talk show “The View” should qualify as a “bona fide news ...

SentinelOne is transitioning from hyper-growth to efficient growth, with strong free cash flow but persistent GAAP losses driven by high stock-based compensation. S achieves robust gross margins (~73% ...

Anthropic will start a drug discovery program focused on "neglected" diseases. The artificial intelligence company announced the effort alongside the announcement of Claude Science, a product designed ...